rs9829896 regulates CREBBP
Evidence from:
primary |
all sources
Evidence (6 sources)
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
consistency of rs9829896 association of expression across KAT2B, CREBBP, and OPRM1 among AAs
confidence: 0.80
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
trans-eQTL pattern between the protective rs9829896-C allele and reduced CREBBP gene expression
confidence: 0.90
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
expression of both genes was down-regulated by the protective allele for drug abuse, rs9829896-C
confidence: 0.94
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
the C allele being associated with lower expression of CREBBP (P=0.011) in AAs only
confidence: 0.90
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896-C allele ... reduced CREBBP expression
confidence: 0.94
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896 as a trans-eQTL for the CREBBP ... genes, using mRNA expression levels measured in human prefrontal cortex
confidence: 0.90